Provided by Tiger Trade Technology Pte. Ltd.

Aquestive Therapeutics Inc.

5.11
+0.09001.79%
Post-market: 5.03-0.0800-1.57%19:36 EDT
Volume:1.91M
Turnover:9.59M
Market Cap:641.05M
PE:-7.85
High:5.13
Open:4.98
Low:4.91
Close:5.02
52wk High:7.55
52wk Low:2.93
Shares:125.45M
Float Shares:115.00M
Volume Ratio:0.60
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6512
EPS(LYR):-0.7836
ROE:148.50%
ROA:-29.20%
PB:-11.33
PE(LYR):-6.52

Loading ...

Aquestive Therapeutics Files Initial Beneficial Ownership Statement for Chief Medical Officer Matthew J. Greenhawt

Reuters
·
Mar 11

Aquestive Therapeutics grants CMO 75,000 restricted stock units and 50,000 stock options under 2022 Inducement Plan

Reuters
·
Mar 10

Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 10

Oppenheimer Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TIPRANKS
·
Mar 09

Leerink Partners Sticks to Its Buy Rating for Aquestive Therapeutics (AQST)

TIPRANKS
·
Mar 06

AI Execution Risks Threaten Aquestive Therapeutics’ Competitiveness and Profitability

TIPRANKS
·
Mar 06

Levi & Korsinsky Files Securities Class Action Against Aquestive Therapeutics

Reuters
·
Mar 06

Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 05

Aquestive misses Q4 revenue estimates, EBITDA loss widens

Reuters
·
Mar 05

BRIEF-Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million

Reuters
·
Mar 05

Aquestive Therapeutics, Inc. Q4 Pretax Profit USD -31.86 Million

THOMSON REUTERS
·
Mar 05

Aquestive Therapeutics Inc - Extends Revenue Sharing Agreement With Rtw to June 30, 2027

THOMSON REUTERS
·
Mar 05

U.S. Earnings Preview: After Market Close March 4

Dow Jones
·
Mar 05

Faruqi & Faruqi Probes Investor Claims Against Aquestive Therapeutics

Reuters
·
Mar 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cogent Biosciences (COGT), Aquestive Therapeutics (AQST) and Merck & Company (MRK)

TIPRANKS
·
Mar 02

Faruqi & Faruqi Probes Potential Investor Claims Against Aquestive Therapeutics

Reuters
·
Feb 25

Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET

GlobeNewswire
·
Feb 24

Aquestive Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Reuters
·
Feb 23